Key result
Ceratonia siliqua extract reduces serum creatinine ~24% and alleviates doxorubicin-induced nephrotoxicity in rats.
Why the study?
Doxorubicin is an effective anti-neoplastic therapy, but its clinical utility is limited by deleterious toxic effects including nephrotoxicity and cardiotoxicity.
Does Ceratonia siliqua methanol extract prevent doxorubicin-induced nephrotoxicity in rats?
Population
5 groups of Wistar rats
Comparison
Ceratonia siliqua methanol extract treatment vs DOX-induced nephrotoxicity
Design
Animal experimental study
Authors
Loading...
Should not yet change practice for doxorubicin nephrotoxicity; leaves open hypothesis-generating potential for Ceratonia siliqua in translational renoprotection research.
Does Ceratonia siliqua methanol extract prevent doxorubicin-induced nephrotoxicity in rats?
Absolute Event Rate: 0.52% vs 0.68%
p-value: p=0.001
Ceratonia siliqua methanol extract effectively alleviates doxorubicin-induced nephrotoxicity in rats via antioxidant, anti-inflammatory, and anti-apoptotic pathways.
Atta et al. (2023) studied Doxorubicin-induced nephrotoxicity (n=35). Ceratonia siliqua methanol extract vs. Doxorubicin alone was evaluated on Serum creatinine (mg/dl) (p=0.001). Ceratonia siliqua methanol extract significantly reduced serum creatinine and alleviated doxorubicin-induced nephrotoxicity via antioxidant, anti-inflammatory, and anti-apoptotic pathways in rats.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: